0001104659-14-022987.txt : 20140326 0001104659-14-022987.hdr.sgml : 20140326 20140326172900 ACCESSION NUMBER: 0001104659-14-022987 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20140324 FILED AS OF DATE: 20140326 DATE AS OF CHANGE: 20140326 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Ophthotech Corp. CENTRAL INDEX KEY: 0001410939 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE PENN PLAZA STREET 2: 19TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10119 BUSINESS PHONE: 212-845-8200 MAIL ADDRESS: STREET 1: ONE PENN PLAZA STREET 2: 19TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10119 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: PEACOCK BRUCE CENTRAL INDEX KEY: 0001228459 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36080 FILM NUMBER: 14719524 4 1 a4.xml 4 X0306 4 2014-03-24 0 0001410939 Ophthotech Corp. OPHT 0001228459 PEACOCK BRUCE C/O OPHTHOTECH CORPORATION ONE PENN PLAZA, 19TH FLOOR NEW YORK NY 10119 0 1 0 0 CFO & CBO Common Stock 2014-03-24 4 M 0 6191 1.6520 A 6191 D Common Stock 2014-03-24 4 S 0 5031 34.71 D 1106 D Common Stock 2014-03-24 4 S 0 1106 35.03 D 0 D Stock Option (Right To Buy) 1.6520 2014-03-24 4 M 0 6191 0.00 D 2020-09-27 Common Stock 6191 66750 D The sale reported on this form was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 14, 2013. These shares were disposed of in multiple transactions on March 24, 2014 at actual sales prices ranging from $33.82 to $34.81 per share. The price reported reflects the weighted average sale price for the transactions. The reporting person undertakes to provide upon request by the staff of the Securities Exchange Commission, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. These shares were disposed of in multiple transactions on March 24, 2014 at actual sales prices ranging from $34.83 to $35.52 per share. The price reported reflects the weighted average sale price for the transactions. The reporting person undertakes to provide upon request by staff of the Securities Exchange Commission, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. This option was granted on September 28, 2010 and is currently exercisable for all shares underlying the option. /s/ Tom Biancardi, as Attorney-in-Fact for Bruce Peacock 2014-03-26